Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5205-5210

  Lin, Fan ^a   Li, Yuyuan ^a   Cao, Jie ^a   Fan, Shaofeng ^a   Wen, Jifeng ^a   Zhu, Guanghui ^a   Du, Hong ^a   Liang, Yanxiao ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; Osteopontin; siRNA

Indexed keywords

ALPHA FETOPROTEIN; MATRIGEL; MESSENGER RNA; OSTEOPONTIN; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER TISSUE; CELL CLONING; CELL INVASION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEOPONTIN; RNA, SMALL INTERFERING; TRANSFECTION; YOUNG ADULT;

EID: 84855235030     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0671-4     Document Type: Article

References (23)

1. Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, Wang L, Zhou J, Qiu SJ, Li Y, Ji XN, Liu H, Xia JL, Wu ZQ, Fan J, Ma ZC, Zhou XD, Lin ZY, Liu KD (2004) A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol 130:187-196 (Pubitemid 38553626)
2. Celett A, Testa D, Staibano S, Merolla F, Guarino V, Castellone MD, Iovine R, Mansueto G, Somma P, De Rosa G, Galli V, Melillo RM, Santoro M (2005) Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferationand invasive-ness. Clin Cancer Res 11:8019-8027 (Pubitemid 41698743)
3. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9:416-423 (Pubitemid 36460075)
4. Chen RX, Xia YH, Xue TC, Ye SL (2010) Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression. Mol Biol Rep. Epub ahead of print
5. Yi B, Qiu YH, Liu C, Luo XJ, Jiang XQ, Tan WF, Wu MC (2010) Hepatic blood inflow occlusion with/without hemi hepatic artery control versus the Pringle maneuver in resection of hepa-tocellular carcinoma: a retrospective comparative analysis. Chin Med J (Engl) 123:1413-1416
6. Qin LX, Tang ZY (2004) Recent progress in predictive bio-markers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol 130:497-513
7. Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW (2005) The molecular signature of metastases of human hepatocellular carcinoma. Oncology 69:23-27 (Pubitemid 41433538)
8. Pan HW, Qu YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98:119-127
9. Takahashi F, Kumasaka T, Nagaoka T, Wakiya M, Fujii H, Shimizu K, Uchida K, Morio Y, Seyama K, Hino O, Takahashi K, Fukuchi Y (2009) Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma. Pathol Int 59:752-756
10. Ue T, Yokozaki H, Kitoda Y, Yamamoto S, Yasui W, Ishikawa T, Tahara E (1998) Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer 79:127-132 (Pubitemid 28201682)
11. Wallach RC (2002) Osteopontin as a biomarker for ovarian cancer. JAMA 287:3208-3209
12. Desilva RS, Martin L, Roshanlall C, Winstanley J, Leinster S, Platt-Higgins A, Carroll J, West C, Barraclough R, Rudland P (2006) Association of S00A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 12:1192-1200 (Pubitemid 43342508)
13. Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16:79-87 (Pubitemid 43247403)
14. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S (2002) Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2:19-24 (Pubitemid 34299209)
15. Huang L, Meng Y, Ren A, Han X, Bai D, Bao L (2009) Response of cementoblast-like cells to mechanical tensile or compressive stress at physiological levels in vitro. Mol Biol Rep 36(7): 1741-1748
16. Chiocchetti A, Orilieri E, Cappellano G, Barizzone N, D' Alfonso S, D' Annunzio G, Lorini R, Ravazzolo R, Cadario F, Martinetti M, Calcaterra V, Cerutti F, Bruno G, Larizza D, Dianzani U (2010) The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population. Int J Immunopathol Pharmacol 23:263-269
17. Ito T, Hashimoto Y, Tanaka E, Kan T, Tsunoda S, Sato F, Higashiyama M, Okumura T, Shimada Y (2006) An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Clin Cancer Res 12:1308-1316 (Pubitemid 43342523)
18. Salvi A, Arici B, Depetro G, Barlati S (2004) Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. Mol Cancer Ther 3:671-678 (Pubitemid 39193747)
19. Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao VH, Sioka C, Rao JS (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J Biol Chem 280:21882-21892 (Pubitemid 40827839)
20. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T (2004) A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 64:3365-3370 (Pubitemid 38657905)
21. Graef T, Steikil U, Nedbal W, Rohr U, Fenk R, Haas R, Kro-nenwett R (2005) Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesis. Angiogenesis 8:361-372
22. Wyatt CA, Geoghegan JC, Brinckerhoff CE (2005) Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res 65:11101-11108 (Pubitemid 41713381)
23. Li Q, Yan W, Cheng S, Guo S, Wang W, Zhang Z, Wang L, Zhang J, Wang W (2006) Introduction of G1 phase arrest in human hepatocellular carcinoma cells (HHCC) by APMCF1 gene transfection through the down-regulation of TIMP3 and up-reg-ulation of the CDK inhibitors p21. Mol Biol Rep 33(4):257-263 (Pubitemid 44760395)